Cure My Disease

Don't miss your cure!

 Log in / Sign up

New antibody drug targets Hard-to-Treat metastatic cancers

NCT ID NCT07292168

Recruiting now Disease control Sponsor: Kidney Cancer Research Bureau Source: ClinicalTrials.gov ↗

First seen Jan 05, 2026 · Last updated Jun 16, 2026 · Updated 27 times

Summary

This study tests a new drug called OM-RCA-01 in people with several types of cancer that have spread to other parts of the body and have a specific marker (FGFR1). The drug is an antibody given through a vein every two weeks. The main goals are to find a safe dose and see if it can slow tumor growth. About 58 adults with kidney, lung, prostate, breast, or head and neck cancer will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • A.I. Kryzhanovsky Krasnoyarsk Regional Cancer Center

    RECRUITING

    Krasnoyarsk, Russia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hadassah Medical

    RECRUITING

    Moscow, Russia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • I.P. Pavlov First Saint Petersburg State Medical University

    RECRUITING

    Saint Petersburg, Russia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Republican Clinical Oncology Dispensary

    RECRUITING

    Ufa, Russia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Republican Dispensary of Tatarstan

    ACTIVE_NOT_RECRUITING

    Kazan', Russia

Conditions

Explore the condition pages connected to this study.

BREAST CANCER METASTATIC HEAD & NECK CANCER HEAD NECK CANCER NON SMALL CELL LUNG CANCER METASTATIC NON-SMALL CELL LUNG CANCER METASTATIC PROSTATE CANCER METASTATIC RENAL CELL CARCINOMA METASTATIC

Conditions inferred from the trial description

These were inferred from the trial's summary, not listed by the trial registrant.

CLEAR CELL RENAL CELL CARCINOMA HEAD AND NECK SQUAMOUS CELL CARCINOMA SALIVARY GLAND CANCER